ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
UK NICE recommends use of Akcea’s Tegsedi for polyneuropathy
April 22, 2019The National Institute for Health and Care Excellence (NICE) in the UK has issued positive recommendation for Akcea Therapeutics’ Tegsedi (inotersen) to treat stage 1 or stage 2 polyneuropathy... -
UK NICE issues second draft ‘no’ on Ninlaro to treat myeloma patients
September 07, 2017The UK National Institute for Health and Care Excellence (NICE) has issued a second draft ‘no’ on Takeda’s Ninlaro (ixazomib) for the treatment of patients with relapsed or refractory myeloma.
Pharma Sources Insight January 2025
